Tuesday, November 30, 2010

Fresenius Kabi Pharmaceuticals Holding Inc. (NASDAQ: APCVZ) Subsidiary Gets OK from FDA to Market Oncology Product

APP Pharmaceuticals Inc. is a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding Inc. focused on the development, manufacture and marketing of injectable pharmaceutical products for the oncology, anti-infective, anesthetic and critical care markets.

The company today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection. The company said it plans to launch the product immediately and anticipates expanding its position in the oncology arena.

Topotecan for Injection is indicated for use in small cell lung cancer sensitive disease when the first-line of chemotherapy has failed. It has also received clearance for use in combination therapy with Cisplatin for stage IV-B, as well as for recurrent or persistent carcinoma of the cervix.

APP’s Topotecan for Injection will enter the market as one of the first generic injectables of its kind. Topotecan is therapeutically equivalent to GlaxoSmithKline’s currently marketed drug Hycamtin®.

John Ducker, president and CEO of APP, noted the importance of a generic form of the product, as well as its value to APP’s product portfolio.

“As one of the first generic entries into the market, APP’s Topotecan for Injection will help reduce the cost of cancer treatment for patients who suffer from cervical and small cell lung cancers,” Ducker stated in the press release. “With the addition of Topotecan for Injection to our growing oncology portfolio, APP continues to demonstrate its ongoing commitment to expanding its presence in the oncology space.”

For more information, visit www.fresenius-kabi.com or www.APPpharma.com

About QualityStocks:

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net

Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net

No comments: